Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Epidemiology of Prostate Cancer in United Arab Emirates

Ghafoor, M., and Schuyten, R., and Bener, A., (2003) Epidemiology of Prostate Cancer in United Arab Emirates. Medical Journal of Malaysia, 58 (5). pp. 712-716. ISSN 0300-5283

Full text not available from this repository.

Affiliations

Ministry of Health.Tawam Hospital.Dept. of Urology, United Arab Emirates
Hamad General Hospital and Hamad Medical Corporation.Dept of. Medical Statistics and Epidemiology, Qatar
Hamad General Hospital and Hamad Medical Corporation.Dept of. Medical Statistics and Epidemiology, Qatar

Abstract

Objective: To evaluate the magnitude of prostate cancer in the United Arab Emirates (UAE). Design: A descriptive retrospective study. Setting: Tawam and Al-Ain Teaching Hospitals, Al-Ain Medical District, UAE. Subjects: Analysis based on patient admissions into the main referral teaching hospital, categorizing age, nationality groups and type of cancer. All prostate cancer patients, diagnosed and treated at Tawam and Al—Ain Hospitals during the period from 1982 to 2000, are included in the study and consisted of 84 subjects. Results: The study series consisted of 84 patients with the ages ranging from 38 to 81 years with a median age of 56 years and a mean and standard deviation of 56.5 ± 12.5 years. The study revealed that majority of the patients (n=33, 39.2%) were diagnosed between 51 to 60 years of age. The majority of our patients were UAE nationals (44.0%), followed by patients from neighboring countries i.e. Oman, Yemen, Syria, Jordan and Egypt (40.5%). The initial pathological diagnosis was confirmed mainly by Trucut Needle Biopsy in the majority of patients (n=48, 57%), TURP (n=15, 18%.), Open Prostatectomy (n=4, 5%) and others i.e. lymph node, bone marrow, and pleural biopsies and high PSA (n=17, 20%). The majority, of our patients (77.7%) presented with an advanced disease and received hormonal treatment while 16.6% received radical radiotherapy and 5.5% had radical prostatectomy. According to our analysis the annual incidence of prostate cancer is 4.5/1 000 000 male population. Conclusion: The prevalence of prostatic carcinoma in the UAE, like other Arabian Gulf and Asian countries, is very low compared to Western Countries despite the high intake of calories and consumption of animal fat. However, genetics and environmental factors believed to be involved in the complex etiology of prostate cancer in UAE are not clear yet, and awaiting investigation.

Item Type:Journal
Keywords:Epidemiology, Prostate cancer, Incidence, United Arab Emirates
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:7024

1. Magrath I and Litvak J. Cancer in developing Countries: Opportunity and challenge. J Nat Cancer Inst. 1993; 85: 862-74.

2. Bener A, Obineche E, Gillett M, Pasha MAH, Bishawi B. Association between blood levels of lead; blood pressure and risk of diabetes and heart disease in workers. Int Arch Occup Environ Health, 2001; 74: 375-78.

3. Keyfitz N and Fliegen W. World population growth and aging: demographic trends in the late twentieth. Chicago University Press, 1990.

4. Bener A, Musaiger AO, Cheema MY, Shalabi A, and Hussein MS. Trends in Cancer during 1989-1992 in UAE. Emirates Journal of Agricultural Sciences, 1994; 6: 156-64.

5. Damber JE. Diet probably plays an important role in the development of prostatic cancer. Lakartidningen; 2000; 97: 3475-80.

6. Cook LS, Goldoft M, Schwartz SM, Weiss NS. Incidence of the adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J. Urol 1999; 161: 152-5.

7. Dhom G. Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate. Res Clin Oncol, 1983; 106: 210-8.

8. La Rosa F et al. Incidence, mortality and long term survival from prostate cancer in Umbria, Italy, 1978-1994. Eur Urol, 2000; 38: 338-92.

9. Hsing AW et al. International trends and patterns of prostate cancer incidence and mortality. International Journal of Cancer, 2000; 85: 60-67.

10. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. 1997, Vol. VII, IARC Sci Pub.

11. Sugandi S. Referral pattern of urological malignancy in Indonesia. Br J Urol 1989; 63: 1-3.

12. Morton RA. Racial differences in adenocarcinoma of the prostate in North American men. Urology, 1994; 44: 637-45.

13. Hanash KA, Al-Othaimeen A, Kattan S, Lindstedt E, Al-Zahrani H, Merdad T, Peracha A, Kardar AH, Aslam M, Al-Akkad A. Prostate carcinoma: A nutritional disease? Conflicting Data from the Kingdom of Saudi Arabia. Journal of Urology, 2000; 164: 1570-572.

14. Deneo-Pellegrini H, De Stefani E, Ronco A, Mendilaharsu M.. Foods, nutrients and prostate cancer, Br J Cancer. 1999; 80: 591-97.

15. Lee MM, Wang RT, Hsing AW, Gu FL, Wang T, Spitz M. Case control study of diet and prostate cancer in China. Cancer Cause Control, 1998: 9: 545-52.

16. Kehinde EO. Prostate cancer in the Middle East: A prospective study from Oman. New prospective in prostate cancer. Oxford Publisher, 1998; 382-90.

17. Mosli HAM. Prostate Cancer in Saudi Arabia - A review of the literature (1975-1996) Annals of Saudi Medicine, 1997; 17: 510-14.

18. Shibata A, Whittemore AS. Genetic predisposition to prostate cancer: possible explanations for ethnic differences in risk. Prostate: 1997; 32: 65-72.

19. Canadian Cancer Statistics, Canadian Cancer Society: International Comparisons: http://www.cancer.ca./ccs/stsndard/0.2704.3172 367655 16546 langId-en.00.html 21/05/2003

Repository Staff Only: item control page